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ABSTRACT  
TAMPERE UNIVERSITY OF TECHNOLOGY 
Master’s Degree Programme in Materials Science 
KHATI, VAMAKSHI: Development of a robust decellularized extracellular matrix 
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Tissue engineering is an interdisciplinary field that has revolutionized the medical world 
by using a combination of biomaterials, bioactive factors and living cells to reconstruct or 
regenerate the damaged/lost tissue. However, there is a crucial need to create a functional 
three dimensional (3D) microarchitecture to efficiently recreate or mimic the spatial and 
chemical complexity inherent to native tissues/organs. 3D bioprinting technology offers 
such unique prospect to produce biological substitutes, as it enables reproducible and 
automated production of complex living tissue constructs. Currently, various types of 
biomaterials have been used for 3D bioprinting, however, these materials are unable to 
exhibit the complexities of the natural extracellular matrix and thus, are incapable to 
provide a suitable microenvironment for seeded cells.  
 
The aim of this thesis is to develop a robust decellularized liver matrix (dLM) bioink, 
which is both cytocompatible and 3D printable. By utilizing the intrinsic functional 
groups present in the decellularized liver matrix proteins, the dLM was modified into a 
3D printable bioink by a cytocompatible gelation mechanism via protein crosslinking by 
homobifunctional Polyethylene glycol with Succinimidyl valerate (SVA-PEG-SVA). The 
active succinimidyl ester reacts with amine groups on gelatin and dLM to form a stable 
amide linkage when incubated at 37°C. The rheological property of this modified, 
temperature responsive bioink measured under oscillatory conditions suggests the 
formation of crosslinked gel after incubation for 30 min and exhibited higher storage 
modulus than loss modulus. Therefore, after gelation, the bioink can retain its structure, 
which is a precondition for developing a cell laden structure. 
 
The optimized bioink rheology, controllable gelation mechanism and bioprinting 
parameters were used to achieve high cell viability and activity. This method of bioink 
production is inexpensive and offers a unique path to generate tissue/organ models for 
screening novel drug compounds or to predict toxicity. 
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1. INTRODUCTION 
Tissue engineering has revolutionized the medical world with the prospect of producing 
artificial tissues and organs by using a combination of biomaterials, different cells and 
biologically active molecules. Application of such technology can fulfill the unmet 
demand of organs and tissue replacements. According to National foundation for 
Transplants the average cost of transplants for organs like liver and heart used to range 
from $50,000 to $1 million (NFT annual report 2010). Along with such high cost and 
limited options, the waiting list of patients has been increasing each year. Tissue 
engineering can provide a potential solution for tissue/organ shortage. Though, this field 
has made substantial progress in last few years, its clinical and medical impacts are 
limited.  A rapid and efficient biofabrication technique is required that can develop 
organs by using the patient’s own cells, alleviating the issue of donated organ rejection 
(Rustad et al. 2010). Three dimensional (3D) bioprinting provides such prospects by 
utilizing a range of materials, including cells and biomaterials, as shown in figure 1, to 
create a 3D structured tissue, in which cell viability and functionality are maintained 
(Makris et al. 2015). The advancements in  tissue engineering and regenerative medicine 
has four important contributing factors that combines different types of cells, scaffolds, 
biochemical factor and 3D bioprinting techniques. Since the introduction of 3D 
bioprinting in late 1990’s, this technique has been driving major innovations in printing 
complex 3D bioscaffolds and tissues, which can be used in transplantation or testing drug 
delivery and toxicology. However, 3D bioprinting is still considered in its embryonic 
stage of development, but it is forecasted to show its impact in the coming years (Tissue 
Engineering and Regenerative Medicine n.d.). In a market research in 2015, 3D 
bioprinting is estimated to be worth a billion dollar industry by year 2019 (Persistent 
market research 2014).  
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Figure 1. The four important elements in tissue engineering today; cells, biochemical 
factor, scaffold and 3D bioprinting (Makris et al. 2015) 
 
Though, 3D bioprinting has expanded tremendously in the past 20 years, one of the main 
challenges to clinical applications of tissue engineering is the difficulty of mimicking or 
recreating the medically effective complex tissue construct. The biomaterials used so far 
are unable to provide the microenvironment for the function and intrinsic morphologies 
of the cells (Pati et al. 2014). There is still a huge demand of both printable and 
biocompatible scaffold material that can closely resemble the chemical complexity of 
native tissue or organ (Murphy & Atala 2014). In some recent years decellularized tissues 
have been reported to be successful in animal studies and human trials as a biological 
scaffold. The removal of cells from a tissue/organ leaves only the extracellular matrix 
(ECM), comprising of complex structural and functional proteins, like collagen. The type 
of tissue, decellularization process and origin of the species from which the ECM is 
extracted vary widely (Crapo 2011). All these factors affect the final characteristics, 
composition and property of the 3D construct. Though, xenogeneic and allogenic tissues 
may have cellular antigens, which may be recognized as foreign by host and elicit 
inflammatory response or tissue rejection in host body, the ECM components are 
evolutionary conserved in all species (Chan 2008). Thus, the ECM component from a 
xenogenic species may be used in the host for tissue replacement provided it is efficiently 
decellularized with minimum or no effect on composition, activity and integrity of 
remaining ECM. These decellularization methods are optimized depending on the origin 
of the tissue to effectively remove all the cellular contents and debris by using a 
combination of physical, chemical and enzymatic processes. Some tissues require less 
extensive decellularization than others depending on the compactness or density of their 
ECM (Crapo 2011). The ECM should be disrupted adequately to expose maximum 
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number of cells to chemicals and enzymes with minimum disruption of native mechanical 
and biological characteristics. Such decellularized extracellular matrices (dECMs) 
scaffolds are biocompatible and can be further developed into a 3D structure using a 
rapid prototyping technique (Ruys 2013). 
 
3D bioprinting is a rapid prototyping technique that requires scaffold materials or bioinks 
to print a 3D shape. The bioink should be printable, easy to handle, mechanically robust 
and biocompatible (Kesti 2013). Usually, the bioink crosslinks during or immediately 
after the printing process to provide mechanical stability and strength. There are various 
types of crosslinking methods used nowadays for polymeric biomaterials that include 
temperature, chemical and ultraviolet (UV) crosslinking. Usually, chemical crosslinking 
and temperature assisted crosslinking provide optimum results, as UV might be harmful 
for the cells. The viscosity of the bioink and the mode of bioprinting play an important 
role in determining its printability (Burdick and Murphy 2012). Extrusion based 
bioprinters are mostly used due to their ability to handle high viscous materials with 
precise control (Murphy & Atala 2014).  
 
The aim of this thesis work was to develop a bioink from liver matrix and introduce 
chemical yet cytocompatible crosslinking strategies to make the bioink robust. For this 
reason, veal liver was decellularized followed by the analysis of the ECM components. 
The decellularized liver matrix (dLM) proteins were then crosslinked with Succinimidyl 
valerate-polyethylene glycol-succinimidyl valerate (SVA-PEG-SVA) with the aid of 
gelatin to form a temperature sensitive bioink that acquires viscoelastic property at 
physiological body temperature in an incubator at 37 ºC and gels at a temperature below 
15 ºC. The mechanical property and degree of crosslinking of the optimized bioink was 
then measured by rheology and 2,4,6-Trinitrobenzene Sulfonic Acid  (TNBS) assay. The 
biocompatibility of the bioink was evaluated by cell viability assay. 3DDiscovery™, an 
extrusion based bioprinter from regenHu was used to print a grid structure at 37 ºC in a 
six well plate. The protein crosslinking with SVA-PEG-SVA formed a robust printable 
bioink with high cell viability that can be further used for printing tissue/organs for 
clinical implantation and pharmacological or toxicological screening. 
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2. THEORETICAL BACKGROUND 
2.1 Bioprinting  
The advancements in tissue engineering in past few years began with accomplishments in 
transplanting the least complex flat organs, i.e. skin, which is made of one type of cell. 
This was followed by progress in developing some simple hollow tissues like blood 
vessels, which is structurally more complex and consists of two cell types (Tissue 
Engineering and Regenerative Medicine n.d.). Next in 2006, more complex organs like 
bladder was synthetically developed in the laboratory and successfully transplanted into a 
patient. Soon, it was realized that developing the most complex organs like heart, kidney 
or liver, is way more challenging than other organs (Atala et al. 2012). This can be 
assumed as the four stages or eras in tissue engineering and regenerative medicine, as 
shown in figure 2, which clearly describes how this field has evolved in the last few years 
(Wake forest school of medicine 2013). Though, there have been successful transplants in 
patients using cells and biodegradable scaffolds, but the need for tissue replacement is 
increasing approximately every 30 seconds.  Thus, a technique or strategy is required in 
this area to deal with this huge demand, which can not only develop organs in a small 
time span, but can also re-create or mimic the actual organ required by the patient (Wake 
forest school of medicine 2013, Wipo.int 2013).   
 
 
Figure 2. The increase in complexity of the engineered constructs with the advancements 
in tissue engineering and regenerative medicine (Wake forest school of medicine 2013) 
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3D bioprinting has emerged as a possible alternative for creating multifunctional complex 
3D organs that is driving major innovations in the area of tissue engineering, medicine, 
biosensor and materials. This technique provides ability to print structures by delivering 
living cells dispersed in a media or scaffold in an organized and defined way, at a specific 
location within the correct environment (Derby 2008, Kundu et al. 2013). It utilizes a 
layer by layer approach to print a user defined 3D construct that mimics the 
microenvironment of the native tissue or organ (Harmon 2013, Atala & Yoo 2015). 
Nowadays this technology is also being used to fabricate 3D functional scaffolds with 
specific biological and mechanical properties (Pati et al. 2014). 
 
There are typically 3 stages of bioprinting process, beginning with a computer aided 
design (CAD) model of the 3D structure that needs to be printed. These CAD models 
basically help to design the exterior as well as the complex interior of the tissue to be 
mimicked (Chua and Yeong 2014). Usually, vasculature, flow rate in microchannels and 
layer by layer configuration are the most complex aspects in the CAD models. The CAD 
model is developed according to the material in use and the type of bioprinter (Kang et al. 
2016). For instance, a laser assisted bioprinter requires photo-crosslinkable scaffold 
material, whereas other printers may not. Once a successful CAD model is ready, then it 
is transferred to the bioprinter to print the 3D construct according to the CAD model, 
which is the second stage in the bioprinting process. In this process, multi-cellular 
building blocks or bioink generates the 3D shape vertically layer by layer. The last stage 
of bioprinting is post processing of the 3D construct, which needs maturation in a 
bioreactor that provides constant flow of media, growth factors and other nutrients at a 
specific temperature and pressure inside the bioreactor (Murphy & Atala 2014, Velasco 
2008). 
 
There are basically 3 types of bioprinting techniques commercially used nowadays. All 
these techniques are capable of patterning and positioning the cells, scaffold and 
biochemical factors in a complex 3D structure. Though the 3 bioprinters have different 
mechanism or style of developing a 3D structure, but there are some common basic 
components of a bioprinter. These components mainly include stage capable of moving 
in z- direction, a dispersion system moving in x-, y- and z- direction (with multiple 
printing cartridges in separate syringes) and a light source illuminating the printing stage 
(Murphy & Atala 2014), as shown in figure 3.   
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Figure 3. Two nozzle system of Organovo’s NovoGen MMX bioprinter (Inhabitat.com 
2012) 
 
Each of the printing process is elaborated more below. 
a) Micro-extrusion: This is one of the easiest, inexpensive and most commonly used 
3D bioprinter technologies. The common components of a micro-extrusion based 
system is a printing stage capable of moving in z- direction, temperature 
controlled material handling and dispersion system moving in x-, y- and z- 
direction comprising of temperature sensor, cartridges and printing nozzle. 
Usually, there is also a light source inside that illuminates the printing area 
(Sreedharan 2014, Murphy & Atala 2014). Some advanced bioprinters have 
multi-nozzle system that can disperse more than one type of media or scaffold 
material and cells without the need of retooling (Sreedharan 2014).  
 
These bioprinters function by controlled micro-extrusion of bioink dispersed 
through a printing head on the printing stage. This technique utilizes continuous 
flow of material through the nozzle, unlike ink-jet bioprinter which uses liquid 
droplets. The continuous material is dispersed according to the computer aided 
design (CAD) design in two dimensions followed by movement of printing stage 
or printing head in z axis to disperse another layer of material on stage (Dai and 
K. Lee 2015, Murphy & Atala 2014). Thus, each layer formed acts as a base or 
foundation for placing next layer (Q. Choi 2015). Usually, there are 3 types of 
techniques to extrude the bioink namely, pneumatic or pressure driven system, 
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piston based system and screw driven system (Murphy & Atala 2014). Each of the 
three systems offers some advantages and disadvantages over one another and 
therefore, they are selected based on specific application. Mechanical dispensing 
system includes piston and screw driven systems (Turksen 2015), as shown in 
figure 4 b) and 4 c), which may enhance the flow control of the material. This is a 
disadvantage for pneumatic based system, shown in figure 4 a) that may have a 
delayed response due to compressed gas volume (Murphy & Atala 2014). 
However, pneumatic based systems have simple components and working, unlike 
mechanical system with more complex parts (Ozbolat and Yu 2013).  
 
Micro-extrusion offers precise deposition of cells and various scaffolds including 
hydrogels and biocompatible polymers. This system allows a wider range of 
biomaterials to be printed since as it is extremely suitable for high- viscosity 
biomaterials with viscosities in the range of 30 mPas
-1
 to 6×10
7
 mPas
-1 
(Jones 
2012, Murphy & Atala 2014). The high viscosity material provides structural 
advantages while low viscosity material provide suitable environment for high 
cell activity and viability. Usually, the biomaterials used in micro-extrusion are 
thermal crosslinked and exhibit shear thinning property that decreases the 
viscosity with increasing shear rate (Guvendiren et al. 2012). These materials are 
either extruded at a temperature where they attain a flowable characteristic.  Some 
materials flow at room temperature and crosslink at body temperature, while 
others flow at physiological body temperature and solidify at room temperature 
(Schuurman et al. 2013). Moreover, the shear thinning behavior eases the flow of 
material during printing process in high shear rate with lower viscosity, which 
increases after printing with lower shear rate resulting in structural stability 
(Murphy & Atala 2014).  
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Figure 4 Micro-extrusion based bioprinter based on 3 techniques, a) Pneumatic 
driven, b) Piston driven or c) Screw driven (Adapted from: Murphy & Atala 2014) 
 
Micro-extrusion bioprinting offers several advantages from high resolution to 
fabricate complex shapes to the ability to deposit high cell densities (Sreedharan 
2014). This results in high self-assembly of cells to accelerate tissue organization. 
However, there are some disadvantages of micro-extrusion as well which includes 
lower cell viability compared to ink-jet printer due to shear stresses in viscous 
material (Chang et al. 2008). Although, the cell viability is maintained by using 
lower pressure and higher nozzle diameter, but this has a negative effect on the 
resolution and speed of the printing process. But with the improvement in 
technology every day, this process is being modified along with the scaffold 
material to suit the demands of cell viability. This technique is currently used in 
fabricating clinical models and in microfluidics as micro-tissues (Murphy & Atala 
2014, Ozbolat & Yu 2013). 
 
b) Ink-jet bioprinting: These types of printers are most widely used for biological as 
well as non-biological applications. They are also called ‘drop on demand’ type 
printers, which functions by heating print head (200-300 ºC) to create pressure 
pulses to force the droplet out from nozzle and are called thermal inkjet printers, 
as shown in figure 5 a). On the other hand, piezoelectric inkjet printers functions 
by creating acoustic waves inside the nozzle or print head to break the liquid flow 
into droplets at regular interval (Turksen 2015), shown in figure 5 b) (Ozbolat & 
Yu 2013). They have an advantage of generating and controlling uniform droplet 
size without exposure of biological molecules to heat or pressure. However, there 
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are concerns regarding the exposure of cells and other molecules to high 
frequency that can potentially damage the cell membrane (Cui et al. 2012).  
Figure 5 Inkjet bioprinter based on a) thermal technique and b) piezoelectric 
technique (Adapted from: Murphy & Atala 2014). 
 
Usually, inkjet printers have advantage of high speed, compatibility, precision and 
wide availability, but they have limitations on material viscosity, which limit their 
uses in various situations and materials. Moreover, these bioprinters usually 
requires liquid form of material to be printed, which post-printing, needs to be 
crosslinked (Murphy & Atala 2014).   
 
c) Laser assisted bioprinting: Laser assisted bioprinting (LAB) is also a bottom up 
technique, which uses pulsed laser energy for inducing transfer of the biomaterial 
from a source layer for spatial pattern of the cellular environment on a substrate 
(Barron et al. 2004). LAB utilizes a pulsed laser beam, a donor slide that has a 
laser energy absorbing layer attached to its bottom and a layer of biomaterial or 
bioink that deposits on a substrate, as shown in figure 6. The laser pulses are 
focused on the absorbing layer to create a high pressure bubble forcing the bioink 
to the substrate at the bottom (Schiele et al. 2010).  
 
The advantage of this technique is its compatibility to print mammalian cells 
without significant loss in cell viability and flexibility with range of materials 
with different viscosity (Koch et al. 2010). However, its disadvantages are its 
relatively high cost, the time consuming layer preparation, contamination of the 
bioink by metallic residues in bioprinted structure and requirement of a rapid 
gelation mechanism of bioink to provide structural stability of the construct. But, 
this technology is improving with the introduction of non-metallic absorption 
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layer and advances in application of patient specific cells in the bioink layer 
(Murphy & Atala 2014). 
 
 
Figure 6. Laser assisted bioprinting with laser pulse to transfer biomaterial from 
donor slide using energy absorbing layer (Adapted from: Murphy & Atala 2014) 
 
2.2 Materials and scaffold 
Currently, there is actually a health crisis in terms of shortage of organs. There are not 
enough organs to fulfill the demand in the medical world. Advancements in medicine are 
making humans live longer as compared to some years back. However, with the ageing 
process and increasing diseases our organs tend to fail more (The Economist 2008). This 
can be understood by graph 1 that highlights the gap between the number of donors, 
recipients and those on an organ waiting list. As of 2013, the numbers of people waiting 
for an organ are more than enough to fill a big football stadium twice. Unfortunately, this 
gap is widening and is estimated to increase further, but the number of donors remains 
relatively the same. With the introduction of 3D bioprinting, scientists are trying to find 
an appropriate scaffold material that would exhibit all the desirable traits of a biomaterial 
that can be used in organ transplants and toxicity (Health Resource and Services 
Administration 2013). 
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Graph 1 Organ supply-demand gap from 2003 to 2013 (Health Resource and Services 
Administration 2013) 
The materials used in bioprinting are either naturally derived like chitosan, gelatin, 
hyaluronic acid that are biocompatible, or synthetic material like PEG, which is 
hydrophilic in nature (Han et al. 2012, Spiller & Lowman 2011, Sun J et al. 2012, Li & 
Kawashita 2011). Both the type of scaffold materials has certain advantages and 
disadvantages over each other. In comparison to synthetic materials, naturally derived 
materials are similar to human ECM with certain amount of bioactivity, whereas 
synthetic materials provide tailored properties (Murphy & Atala 2014). The choice of 
biomaterial depends on the final application intended. ECM from xenogenic species is 
also used as a scaffold material nowadays owing to its biocompatibility and printability 
(Hinderer 2015). All these materials are studied extensively nowadays in tissue 
engineering (development of hollow organs, two dimensional (2D) tissues or solid 
organs), as shown in figure 7.  
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Figure 7. Scaffold material types; synthetic, natural and extracellular matrix (ECM) with 
their respective applications in tissue engineering nowadays (Adapted from: Murphy & 
Atala 2014) 
 
With extensive development in 3D bioprinting, the required characteristics or traits in 
biomaterials is also increasing. Printability of the material is the most important criteria 
that qualify the use of that material in bioprinting process for precise and controlled 
dispersion and deposition of the biomaterial (Nair et al. 2009). Moreover, some rapid 
crosslinking mechanisms are also required in some bioprinting techniques to facilitate 3D 
structure formation. Thus, the compatibility of the material for bioprinting is determined 
by viscosity and thermal conductivity of material to be dispersed, the nozzle diameter, 
crosslinking mechanism and biocompatibility. Scaffold materials are expected to be 
bioactive and produce the desired effects in the body (Williams 2008). The printed 
construct is expected to interact with the host body and support cellular activity and 
signaling of molecules after a successful transplantation. Also, the biomaterial is 
expected to have either no or non-toxic degradation products that are readily removed 
and metabolized without affecting the cellular activity and functions (O'Brien 2011, 
Murphy & Atala 2014). The degradation of the scaffold should be in balance with the 
cellular ECM production to support the growth of the tissue. For this reason, maintenance 
of structural and mechanical characteristics of the printed construct is an important and 
challenging concern. The printed construct with the mechanical and structural 
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characteristics should maintain their traits for continued functions even after 
transplantation in host (Ozbolat and Yu 2013). Usually, the scaffold material is sacrificial 
that helps in crosslinking during printing or incorporated in the 3D construct until the 
biomaterial can carry its own function . Thus, the design of the printed construct is 
chosen carefully that would influence the cellular response and effective degradation 
properties without any side-effects (Chia and Wu 2015, Murphy & Atala 2014). 
 
Biomimicry refers to mimicking the biological characteristics or environment present in 
the target tissue or organ. The biomimetic components in printed construct can positively 
affect the cellular response in the scaffold (Hopp et al. 2005). These components include 
ligands, growth factors or cell-adhesion/promoting factors like RGD along with tissue 
specific 3D environment and ECM like scaffold composition. This can be achieved by 
using dECM of the target organ as scaffold material, which retains the growth factors and 
ECM binding proteins. These proteins provide structure and strength, bind with growth 
factors and promote cellular response in the scaffold (Hersel et al. 2003, Shin et al. 2003).      
2.3 Decellularization of extracellular matrix 
Decellularization is a process of removal of cell contents from a tissue, leaving the ECM 
components of the scaffold, as shown in figure 8. This dECM is isolated from the cells 
and hence used in tissue regeneration. Usually, organ rejections are due to several 
immunological barrier and cellular rejections. This results in lifelong immunosuppressing 
drug prescriptions for the organ transplant recipients (Colaco & Atala 2014). However, 
the adverse immune response can be eliminated if dECM is used as a scaffold for organ 
transplantation and recellularizing it with patient specific cells (Gilbert et al. 2006).  
 
Figure 8 a) Native tissue with cells and ECM together b) Decellularized tissue without 
cells (Wake forest school of medicine 2013) 
The main aim of decellularization process is to maximize the cell lysing, killing and 
removal with minimum loss of ECM components and its chemical integrity. For this, 3 
a) b) 
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types of decellularizing processes are used; physical, chemical and enzymatic treatments 
(Gilbert et al. 2006). The decellularization step is a combination of these 3 treatments 
depending on the type of tissue, its origin and components. For instance, a dense tissue 
like cartilage would require an extensive decellularization treatment than a less dense 
tissue like heart.  
 
A physical treatment includes temperature, pressure and force being applied on the target 
tissue. When these tissues are rapidly frozen and thawed, ice is formed around cell 
plasma membrane in microscopic level, which results in cell lysing (Flynn 2010). The 
temperature treatment is handled well by thick tissues usually, whereas, pressure 
application on the ECM will certainly disrupt its structure. Thus, physical methods are 
usually followed by chemical and enzymatic treatments, which further remove the cell 
contents (Fu et al. 2014). 
 
Chemical treatment involves acids, alkaline, ionic and non-ionic detergents to be used to 
kill and remove cells (Fu et al. 2014). Chemicals are used according to the thickness and 
components of the ECM.  Sodium dodecyl sulfate (SDS) is the most commonly used 
ionic detergent, which is highly efficient in lysing cell membrane and thus, exposing the 
cellular contents for further degradation (Lumpkins et al. 2008). It slightly disrupts the 
ECM components.TritonX-100 is a non-ionic detergent that effectively disrupts the 
interaction between lipids and between lipids and proteins. It is efficient to use TritonX-
100 after SDS as it does not disrupt the protein-protein interactions between the ECM 
components. Peracetic acid is used as disinfecting agent at the end of the decellularization 
process to remove nucleic acid with minimum effect on ECM (Gilbert et al. 2008). 
 
Enzymatic treatment includes endonucleases and exonucleases that eliminate interactions 
and bonds between nucleic acids and cellular components and degrade genetic material 
(Petersen et al. 2010). However, this treatment is not used when collagen is required in 
the ECM as it would disrupt the fibers in connective tissue. Enzymes like trypsin also 
break the interactions between adherent proteins between cells and cell-ECM. Trypsin 
helps in protein digestion in cell culture which helps the cells to adhere to the surface of 
the vessel (Waldop et al. 1980). The decellularization process in this work was utilized to 
recellularize the bovine dLM with mammalian cell line and study its effect.  
2.4 Liver  
Liver is the largest gland in human body present in the abdominal cavity that performs a 
range of important functions including synthesis of various proteins, nutrient inter-
conversion, detoxification, storage, bile production, metabolism, and phagocytosis 
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(Gannon & Curley 2008). It is the largest internal organ, which is reddish brown in color 
and weighs about 1/50
th 
of adult body weight. It is a unique organ that can renew itself 
and regenerate 2/3
rd
 of its mass. Liver is a heterogeneous tissue organized into a 
hierarchical structure making it functionally and structurally complex (Kuntz and Kuntz 
2006). The liver is the major source of metabolism and drug biotransformation, thus liver 
cells are a logical choice for toxicological and pharmacological testing nowadays. Liver 
specific cells, hepatocytes, make up 70- 80% of the mass of the liver (Apte 2015). The 
main function of hepatocytes includes synthesis of collagen and extracellular matrix, 
cholesterol, bile salts and phospholipids, detoxification from exogenous materials and 
transforming carbohydrates (American Cancer Society 2010, Kmieć 2001).  
 
The extracellular matrix (ECM) occupies a small percentage of the volume of the normal 
liver, yet plays a disproportionately important role in liver function in health and disease. 
Extracellular matrix is secreted by the cells that populate the liver, which in turn affect 
the cell phenotype and behavior. In general, ECM composition and structure affects the 
cell migration, attachment and proliferation (Stocum 2012). Moreover, the proteins in the 
ECM play a vital role in protein regulation, signaling molecules and architectural 
elements (Turner et al. 2010). These proteins are responsible for maintaining the 
differentiated state of normal hepatocytes and non-parenchymal cells in liver. For these 
reasons, liver ECM can play an important role as a biological scaffold to provide 
structure and space filling properties. ECM proteins like collagen or glycosaminoglycans 
(GAGs) can alter cell behavior, regulate growth factors and increase the in vivo response 
of scaffold material (Karsdal et al. 2013).  
 
Collagen is the most abundant protein in the extracellular matrix present as elongated 
fibrils that provide structural support to the cells. Collagen has a long triple stranded 
helical structure consisting of three polypeptide chains out of which two have similar 
chemical composition (α1 α2) (Lodish 2000). There are approximately 28 types of 
different collagen in human body, which are either fibrillar or non-fibrillar. Collagen 
provides structural strength to an organ (Royce and Steinmann 1993, Ricard-Blum 2010). 
Collagen and GAGs are both important components of the ECM. They play a vital role in 
attachment, survival, migration and proliferation of the cells. Usually, collagen fibers are 
embedded or covered in the GAGs rich matrix, which makes GAGs more susceptible to 
decellularization process as compared to collagen (Xu et al. 2014). However, the tensile 
properties of the   organ are directly related to the collagen content. It has also been noted 
in some studies that removal of GAGs content does not affect the tensile strength of some 
tissues (Han et al. 2012). 
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2.5 Crosslinking strategies for decellularized liver matrix 
In this work, gelatin and SVA-PEG-SVA were utilized to substantially enhance the 
properties of the dLM to make it robust yet compatible for the printing process. Proteins 
and collagen have long history in the field of medicine and pharmaceutical studies. 
Gelatin was used as a formulation enhancer with dLM, wherein they crosslinks with the 
SVA-PEG-SVA to form stable amide bonds. 
Gelatin 
Gelatin is the hydrolyzed product of collagen. The collagen is partially hydrolysed 
breaking the molecular bonds between individual collagen strands and broken into 
random coils. The chemical composition of gelatin closely resembles collagen as it 
retains some cell-binding motifs, such as RGD (Arg-Gly-Asp) (Zhu and Marchant 2011).  
Gelatin has already become a commonly used biomaterial for vascular network 
engineering (Liu et al. 2015). Gelatin has already been used in food, pharmaceutical 
studies, cosmetics and medicine due to its lost cost and availability, biocompatibility, 
biodegradability and low antigenicity. It does not leave any harmful by products during 
enzymatic degradation in the body (Hoque 2015).  
 
Gelatin is a thermo-responsive biomaterial, which has an upper melting point at round 
35°C (Huang et al. 2004).  It has high amount of accessible functional groups for 
modification during crosslinking (Hoque 2015). It shows viscoelastic flow at 
physiological body temperature but as the temperature decreases, the viscosity starts to 
increase (Zhang et al. 2004). Gelatin forms a rigid inflowable gel at a temperature below 
20 °C. In this thesis, gelatin is used as a formulation enhancer, which crosslinks with 
SVA-PEG-SVA along with dLM to form amide bond.  
Homobifunctional Polyethylene Glycol (SVA-PEG-SVA) 
Polyethylene glycol (PEG) is a food and drug administration (FDA) approved biomaterial 
that is capable of attaching itself to proteins via a variety of chemical reactions. The 
addition of PEG chain to a macrostructure is called PEGylation. Usually, proteins or 
peptides are modified with the PEGylation process to improve their efficiency and safety 
as drugs (Harris and Chess 2003). The change observed with PEGylation of a drug 
includes change in its hydrophobicity, immunogenicity, hydrodynamic size, 
conformation and electrostatic binding, which helps in increasing the systemic retention 
of the drugs. The main advantage of using PEG commercially is due to its low toxicity 
and ready clearance from the body (Veronese and Mero 2008). 
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The PEGylation process begins with addition of functionalized groups at one or both the 
ends of the PEG polymer. If the reactive moiety at both ends is identical, then it is called 
a homobifunctional molecule, but if there are two different functional groups, then it is 
termed as heterobifunctional molecule (Williams 2010), as shown in figure 9. Now, the 
choice of the functional group to be coupled with PEG depends on the available target 
group present on the macrostructure.  In case of proteins, like collagen present in the 
extracellular matrix, which contains various amine groups including glycine, proline and 
hydroxyproline, the addition of a carboxylic end group on PEG can form stable amide 
linkage with N terminus of the amino group (Hamley 2014, Rutz et al. 2015).  
 
O
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N
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O
OCCH2CH2CH2CH2O(CH2CH2O)nCH2CH2CH2CH2CO N
     
Figure 9. Chemical structure of SVA-PEG SVA, a heterobifunctional molecule (Laysan 
bio Inc 2015) 
 
Succinimidyl valerate is an active ester which forms a homobifunctional PEG ending in 
two reactive groups (Laysan Bio Inc 2015). It behaves as a chemical crosslinker reacting 
with primary or secondary amines on the protein chains forming stable amide linkages, as 
shown in figure 10. This conjugated PEG on the peptide chain provides flexibility and 
elasticity that allows cell adhesion and migration (Rutz et al. 2015) 
 
Figure 10. PEGylation of collagen chain with SVA-PEG-SVA resulting in formation of 
amide linkages (Adapted from: Dana et al. 2011) 
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3. MATERIALS AND METHODS 
3.1 Materials 
Mainly, two types of materials were used to modify the dLM, namely, gelatin and SVA-
PEG-SVA. Powdered type-A gelatin derived from porcine skin was bought from Sigma-
Aldrich. The bloom number of gelatin was 300g, which determines the strength of the gel 
formed from water solution. On the other hand, homobifunctional Polyethylene glycol 
ending with two reactive succinimidyl valerate groups was bought from Laysans bio. 
USA with 1000 molecular weight (MW).  The rest of the chemicals used in the thesis 
were bought from Sigma-Aldrich.  
 
Table 1: Materials used in this study for decellularization, papain digestion, 
hydroxyproline assay, DMMB assay and TNBS assay with their molecular weight (MW) 
or concentration. 
Chemical MW/Concentration 
Decellularization  
Sodium dodecyl sulphate (SDS) 288.8 g/mol 
Triton-X 625 (average molecular weight) 
Peracetic  acid 76.05 g/mol 
Papain digestion solution  
Sodium phosphate 156 g/mol 
Ethylenediaminetetraacetic acid (EDTA) 292.18 g/mol 
Cysteine-HCl 157.62 g/mol 
Papain 23,406 Da 
Hydroxyproline assay  
Hydroxyproline 131.12 g/mol 
Chloramine T 281.69 g/mol 
p-dimethylaminobenzaldehyde (p-dab) 149.19 g/mol 
DMMB assay  
DMMB 416.05 g/mol 
Bisbenzimide Hoescht 533.8 g/mol 
Pepsin from porcine gastric mucosa 2.5 mg /ml 
Acetic acid 99% 
TNBS assay  
TNBSA 293.79% 
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3.2 Methods 
3.2.1 Decellularization of the liver 
Decellularization is the primary step to develop the bioink, for which, fresh veal liver was 
collected from a local butcher shop and thawed to 4 °C prior to use. The decellularization 
protocol followed was slightly modified than the protocol published elsewhere (Uygun 
and Lee 2011). Next, it was washed with phosphate buffer saline (PBS) solution for an 
hour to remove blood in the tissue and then cut into 1 mm pieces. The chopped liver 
tissue was stirred with varying concentration of sodium dodecyl sulfate (SDS) solution 
for 3 days followed by treatment with 1% triton-X for about an hour, as shown in figure 
11. At the end, the decellularized extracellular matrix was washed with water for the 
complete removal of Triton-X, followed by a disinfection step with 0.1% peracetic acid 
in 4% ethanol for 3 h. Finally, the sterile dLM was washed with autoclaved water for 1 
day. The obtained dLM was lyophilized and stored at -20° C in a freezer. The whole 
process of decellularization was optimized to obtain high collagen and GAGs content and 
minimum DNA and cell nuclei. 
 
 
 
Figure 11 .The decellularization process for liver tissue 
 
 
 
Wash with PBS 
and cut to 1 mm 
pieces 
Wash with 
0.01% SDS 
Wash with 0.1% 
SDS 
Wash with 1% 
SDS 
Wash with 1% 
Triton-X 
Wash with water 
Wash with 0.1% 
Peracetic acid + 
4% ethanol 
Wash with milliQ 
water 3 times 
20 
 
3.2.2 Biochemical characterization of the decellularized liver 
matrix 
The samples for DNA quantification, Hydroxyproline assay for collagen and 
Dimethylene methyl blue assay for glycosaminoglycans were estimated according to 
varying concentration, where the mean of 3 samples was plotted in the graph in Appendix 
1 with regression values demonstrating the significance of data analysis 
3.2.2.1 DNA quantification 
To verify the efficiency of the decellularization process, the residual DNA in the dLM 
was calculated, as previously conducted elsewhere (Pati et al. 2014). For this, 10 mg of 
each dLM and native tissue were digested in 1 ml papain digestion solution. The papain 
digestion solution was prepared by mixing 125 μg ml−1 papain in 0.1 M sodium 
phosphate, 5 millimolar (mM) disodium-Ethylenediaminetetraacetic acid (Na2-EDTA) 
and 5 mM cysteine-hydrochloric acid (HCl) at pH 6.5 for 16 h at 60° C (Patchigolla et al. 
2012). Papain solution without sample was also incubated to be used as a diluent. These 
papain digested samples were used in other biochemical assays as well (hydroxyproline 
assay). The DNA was quantitated using Hoechst 33258 (Bisbenzimide dye) in a 
fluorometric assay (Murphy & Sambanis 2001). The process requires a DNA standard 
calibration curve to determine the DNA content in a sample. Calf thymus DNA (1mg/ml) 
was used as a standard in order to quantify DNA in native tissue and the dLM. Triplicates 
of the standard were prepared according to the table 2: 
Table 2. Standard curve for 10×10 cuvette (Murphy & Sambanis 2001) 
2X DNA solution 
conc. (ng/ml) 
Volume of 2X DNA 
solution (ml) 
Volume of 2X 
dye solution (ml) 
Final DNA conc. In 
Hoechst assay (ng/ml) 
10000 1 1 10000 
5000 1 1 5000 
2000 1 1 1000 
1000 1 1 500 
500 1 1 250 
200 1 1 100 
100 1 1 50 
50 1 1 25 
20 1 1 10 
0 1 1 BLANK 
  
Thereafter, 100 µl of dye was added to each well of the cuvette. Lastly, a fluorescence 
spectrophotometer was used to measure fluorescence intensity at excitation wavelength 
of 360 nm and emission at 450nm to calculate the remaining DNA within the dLM and 
the native tissue. 
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3.2.2.2 Hydroxyproline assay 
Matrix collagen before and after decellularization was also estimated and compared by a 
conventional hydroxyproline quantitation assay. The whole process can be divided into 3 
major steps for clear understanding. The protocol followed for hydroxyproline assay was 
slightly modified than described elsewhere (Williams et al. 2005). 
 
Firstly, the papain digested dLM and native tissues (refer to section 3.2.2.1) were acid 
hydrolysed with equal volume of concentrated HCl at 120 ºC for about 12 h. The residues 
were then dried at 90 ºC for approx. 12 h and cooled to room temperature (RT). This was 
followed by re-dissolving the samples in 1ml 0.25M sodium phosphate buffer. The above 
same steps were used to make hydrolysed papain digestion solution. 100 µg/ml 
hydroxyproline solution was used a standard.  
 
The next step is to prepare hydroxyproline standard solutions for assay calibration. For 
this purpose, standard stock solution was diluted with hydrolysed digestion solution to 0, 
1, 2, 3, 4, 5, 6, 8, 10, 15, 20, 30 µg/ml. The last step is to quantify total collagen content 
in the tissues. Both the dLM and the native tissue samples were diluted with 1:10 with 
hydrolysed papain solution.  Aliquot in triplicates of 50 µl samples, standards, hydrolysed 
papain solution in a 96 well assay plate. Then, add 50 µl of chloramine T solution 
(prepared immediately before use) to each well and incubate the plate for 20 min at RT. 
Next, add 50 µl of p-DAB solution (prepared immediately before use) to each well and 
incubate again for 30 min at 60 ºC in a water bath. Lastly, incubate the plate at room 
temperature for some time and measure the absorbance at 540 nm in a spectrometer 
(Mahbuba Farooque 2008). 
3.2.2.3 Dimethyl methylene blue assay 
Dimethyl methylene blue assay (DMMB) assay was performed to measure the sulfated 
GAGs using 1,9-dimethylmethylene blue solution in the papain digested dLM and native 
tissue  (refer to 3.2.2.2). Firstly, DMMB dye was prepared in 1 L milliQ water by diluting 
16mg DMMB dye, 3.04g glycine and 2.37g Sodium Chloride (NaCl). The pH of the 
solution was adjusted to 3 and left overnight covered with aluminium foil to dissolve. 
The solution was then filtered with 0.22 µm filter.  
 
This was followed by the DMMB assay in which 10mg/ml chondroitin sulfate A was 
used as stock solution.   Various concentrations of chondroitin sulfate were prepared and 
triplicates were aliquoted in a 96 well assay plate. Next, 50 µl of papain digested samples 
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were added to each well followed by addition of 200 µl DMMB dye. At the end, the plate 
was read at 492 nm using a plate reader (Buschmann et al. 1995).  
3.2.3 Preparation of decellularized liver matrix bioink 
For changing the decellularized tissue into a bioprintable gel, the primary step was to 
solubilize the tissue to get a final concentration around 3%. This protocol for pepsin 
digestion is slightly modified as described elsewhere (Pati et al. 2014). For this, 100 mg 
lyophilized decellularized tissue was weighed and digested in 0.5 M acetic acid and 10 
mg pepsin for 48 h. After complete digestion, the solubilized dLM was centrifuged to 
separate any undissolved particles. However, this solubilized dLM was acidic in nature 
and thus required adjusting the pH to be used for biological applications. The pH was 
adjusted to 7 by addition of cold 10 M Sodium Hydroxide (NaOH) at a temperature 
below 10° C to avoid gelation of the dLM. This pH adjusted dLM below 15 ºC was called 
dLM pre-gel and after gelation at 37 ºC was called pH adjusted dLM (Pati et al. 2014).  
 
Required amount of dLM pre-gel was weighed and added to 250 µl gelatin at a 
temperature below 10° C. In this mixture, 55 µl of SVA-PEG-SVA was added and mixed 
on vortex. The mixture was then put in incubator for about 2 h after which the dLM 
bioink was formed.   
3.2.4 Characterization of modified decellularized liver matrix 
3.2.4.1 Rheology 
Rheological measurements were performed to evaluate material properties like viscosity 
and modulus of pH adjusted dLM, dLM-gelatin, dLM-PEG and dLM bioink. The 
experiments were performed using dynamic shear rheometer TA instruments dynamic 
shear rheomter AR-1000 equipped with 25 mm dimeter parallel plate setup. The zero gap 
was adjusted to 300 microns before every measurement for accuracy during experiments. 
Flow characteristics were measured in continuous ramp test mode in shear rate of 1-100 
1/s at 37 ºC. Prior to rheology tests, the samples were incubated at 37 ºC for 2 h. The 
samples were then loaded on a 25 mm parallel plate system. After loading the samples 
and adjusting the gap, the viscosity measurements in continuous ramp mode and 
oscillatory frequency measurements were taken. Modulus was measured in oscillatory 
frequency conditions at 37 ºC with frequency range from 5 to 100 rad/s and 1% strain. 
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3.2.4.2 TNBS assay 
For estimating the number of primary amines which have not been crosslinked 
Trinitrobenzenesulfonic acid (TNBS) assay was performed. 5 mg of each dLM bioink, 
pH adjusted dLM, dLM-gelatin and dLM-PEG were taken as samples.  Each sample was 
dissolved in 4% by weight sodium bicarbonate (pH 8.5) reaction buffer and dissolved at 
25 °C for 40 min. Next, 0.5% by weight TNBS solution was added to all samples and put 
in incubator at 40°C for 2 h under mild shaking. Thereafter, 3ml of 6 M HCl was added 
to that mixture and heated at 60 °C to dissolve remaining residues of sample for 90 min. 
The solutions were then cooled to room temperature and extracted three times with 
anhydrous diethyl ether to remove non-reacted TNBS. All samples were then read against 
a blank prepared by the above procedure, except that HCl was added before TNBS, at 
absorbance of 335 nm in spectrophotometer. The value of blank was subtracted from the 
absorbance of each sample. dLM pre-gel was assumed to contain 100% free amine 
groups and this value was utilized to compare the percentage of free amine groups in 
dLM bioink, pH adjusted dLM, dLM-PEG and dLM-gelatin after incubating them for 2 h 
at 37ºC (Tronci et al. 2013, Davidenko et al. 2015). 
3.2.4.3 Cell viability and activity  
Immortal pancreatic cell line was obtained from the Scilifelab facility and used for 
assessment of the efficiency and effectiveness of crosslinked gel. 900 µl of crosslinked 
gel at a temperature below 15 ºC was mixed with 100 µl of 2x Dulbecco’s modified 
Eagle’s medium (DMEM). In this gel, adherent pancreatic cells were added in a 
concentration of approximately 10
6
-10
7 
cells/ml and mixed in vortex at low speed to get 
uniform cell concentration. Lastly, the cell laden scaffold was added in a 6 well plate in 
form of an extremely thin layer, which was followed by addition of 1x DMEM 
containing 10% fetal bovine serum (FBS). The plate was then put in an incubator at 37 ºC 
and 5% CO2.  
 
To estimate the proliferation and cell viability of the cells MTT (3-(4,5-dimethylthiazol-
2-yl)-2,5-dipHenyltetrazolium bromide) tetrazolium was used. The cell proliferation rate 
was measured in 1, 4 and 7 days from the day of cell culture.  Stock solution of Yellow 
MTT powder was made in PBS (5 mg/ml) under sterile conditions. The cell laden 
scaffold was first washed with PBS. Thereafter, the scaffold was incubated with 360 µl of 
DMEM media and 40 µl of MTT stock at 37 ºC and 5% CO2 (Pati et al. 2012). After 2-3 
h, purple colored formazan precipitate was seen, which is formed by the reduction of 
MTT by metabolically active cells. This precipitate was dissolved with 400 µl of DMSO 
and shaken. After 15 min, aliquots in triplicates were made in a 96 well plate and read at 
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590 nm in a spectrometer. Three independent experiments were performed for 
calculations (Chen et al. 2013). 
   
Fluorescence based Live/Dead cell assay evaluates the viability of cells in the dLM 
bioink. Cell viability of the scaffold was conducted at day 1, 4 and 7, which discriminates 
the live cell population from dead cell population (Thevenot et al. 2008). The assay uses 
two types of fluorescent dyes that stain live and dead cells. Calcein AM was used to stain 
the live cells whereas ethidium homodimer was used to stain the dead cells. This protocol 
is applicable to all type of cells in the matrix; adherent cells, cells in embedded in ECM 
as well as cellular clusters (ibdi 2015).  The assay dye was prepared by mixing 2 µl of 
calcein AM and 4 µl ethidium homodimer in sterile PBS (stock solution). The cell laden 
bioink was first washed with PBS on the requisite day to dilute and eliminate the activity 
of serum esterase that might be present in DMEM or similar serum supplemented growth 
media (Pati et al. 2014). Next, 100-200 µl of stock solution of dye was added to the 
scaffold and incubated for 30 minutes at 37 ºC. The scaffold was then visualized in 
Axioplan 2 imaging fluorescence microscope (Correia et al. 2011). 
3.2.5 Bioprinting 
Finally, 3D bioprinting of the dLM bioink was performed using 3DDiscovery™, an 
extrusion based bioprinter that is capable of printing very precise structures in the range 
of 5 microns. The printer uses pneumatically driven with the help of compression air 
controls for high resolution printing. It is used to study 3D tissue models and identify 
various parameters including cellular interactions and proliferation, drug metabolism and 
differentiation (regenHu datasheet 2015). It is equipped with 2-3 nozzles for printing 
several materials along with temperature control in a sterile environment inside glass box 
as shown in figure 12 a). The aim of the work was to print a simple grid structure, as 
shown in figure 12 b) designed in SolidEdge software, to check the printability of the 
dLM bioink.  
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Figure 12. a) 3DDiscovery™ bioprinter used for bioprinting b) 2 layer grid structure to 
be printed (Rutz et al. 2015) 
 
After incubating bioink at 37 ºC for 2 h, it was added in one syringe with approximately 2 
ml volume and loaded to the bioprinter with 300 µm nozzle diameter. The temperature 
was controlled at 37 ºC to maintain printability. The printing speed was  optimised for 
obtaining the maximum throughput and good structure. Once the first layer was printed 
the printing head moved up in z axis to print the seond layer. Thus the final structure was 
printed in a matter of few minutes. 
3.2.6 Statistical Analysis 
All the data in this work is represented by mean ± standard deviation, performed in 
Microsoft Excel 2013. The significance was statically determined at p value <0.05.  
 
 
b) 
a) 
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4. RESULTS AND DISCUSSION 
4.1 Decellularization of liver tissue 
The preparation of bioink for bioprinting consists of few steps as shown in figure 13. The 
process begins with the decellularization of the native liver tissue in which the aim is to 
maximize the removal of the cellular entities with minimum loss to the ECM 
components. 
  
Figure 13. Schematic diagram elucidating development of dLM bioink for bioprinting 
 
This work reports successful decellularization of the liver tissue after treating it with a 
combination of physical and chemical decellularization process. These processes are 
slightly modified and optimized than the procedure described elsewhere (Mazza et al. 
2015). Moreover, peracetic acid and was used as a sterilization step at the end of the 
decellularization process (Freytes et al. 2008). The reddish brown color of the native liver 
turned white after the complete decellularization treatment showing the successful 
removal of the cellular material, as seen in figure 14.  Regrettably, the natural 3D 
organization of the native liver tissue is lost in this study; however, the desired ECM 
components (GAGs and collagen) were successfully retained after the decellularization. 
The main concern while decellularizing was to minimize the loss of material in the 
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process, as 100 g of native tissue decreased to 20 g of decellularized tissue after the 
completion of decellularization process.  
 
 
Figure 14. Native tissue (left) and decellularized tissue (right) 
4.2 Extracellular matrix components 
The efficiency of this decellularized tissue was evaluated by DNA quantification. The 
remaining collagen and GAGs content was also evaluated. DNA quantification resulted 
in optimal removal of the cell contents with 98.43 % removal of DNA and approx. 1.7% 
remaining in the dECM of liver tissue. Thus, it can be said that the native liver tissue is 
completely decellularized.  
Figure 15. DNA, GAGs and Collagen (Col) content in decellularized extracellular matrix 
(dECM) of liver. All the experiments done in triplicates. (Appendix 1 for Regression 
values) 
 Before decellularization                         After decellularization 
28 
 
Other ECM components like collagen and GAGs were also estimated in native and 
decelullarized tissue. The hydroxyproline assay showed 89.8% of collagen content in 
decellularized tissue, whereas, DMMB assay showed 26.5% of remaining GAGs content 
in decellularized tissue as compared to the native tissue, as shown in figure 15. The 
noteworthy loss in GAGs content is due to the use of SDS in the decellularization 
process, which is known to be destructive for GAGs. On the other hand, the 
decellularization process had least effect on the collagen content. SDS is a harsh 
detergent that is very effective in removing nuclei and penetrating into the thick and 
dense like liver tissue during decellularization process. Decellularization process of liver 
tissue without SDS treatment would be incomplete and result in visible nuclei and DNA 
content (Yang et al. 2014). Regrettably, this decellularization process resulted in loss of 
GAGs, however, in this work; high collagen content was prioritized since the 
development of a 3D construct would require the structural properties of collagen.  This 
notable presence of various proteins in the dLM will further ensure advantages in 
bioprinting of the dLM bioink. Further analysis can be done to measure the presence of 
growth factors in the decellularized liver tissue, which will provide an estimation of the 
growth factors retained after the decellularization process. Moreover, SDS PAGE would 
also provide information about the presence of various proteins or peptides within the 
decellularized liver tissue.  
4.3 Preparation of decellularized liver matrix bioink 
The central approach to this thesis is development of a printable dLM bioink. The 
preliminary step in this approach is to convert the dLM tissue into dLM pre-gel by 
continuously dissolving dLM in acetic acid and pepsin for 2 days. The pepsin cleaved the 
telopeptide region of collagen and thus formed 3% dLM solution in acetic acid, as shown 
in figure 16 (left). The resultant gel was acidic in nature and thus not suitable to be used 
as a biological scaffold. Therefore, the pH of the gel was adjusted to 7 at a temperature 
below 15 ºC to avoid gelation. This dLM pre-gel is a thermoresponsive biomaterial that 
behaves as a flowable liquid at a temperature below 15 ºC and becomes gel after 
incubation for 30 mins at 37 ºC, as shown in figure 16 (right). 
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Figure 16. Formation of gel from decellularized liver tissue (left) and pH adjusted dLM 
from dLM pre-gel(right) at different temperature. 
 
The initial approach in this thesis was to utilize only SVA-PEG-SVA for preparing the 
robust bioink. However, it was observed that crosslinking SVA-PEG-SVA with pH 
adjusted dLM failed to impart the required viscoelastic property at 37 ºC.  It behaved as a 
liquid at a temperature below 15 ºC and formed a gel at 37 ºC after incubating for 1 hour, 
as shown in figure 17. Thus, the use of gelatin was considered along with SVA-PEG-
SVA, as gelatin has been long known for its viscoelastic nature. Gelatin with dLM 
exhibited better viscoelastic property than dLM-PEG, however, using both these 
materials with dLM increased the robustness and viscoelastic nature of the required 
bioink. After preparing various formulations at different concentrations of the dLM with 
gelatin and SVA-PEG-SVA, only one exhibited great viscoelasticity. 
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Figure 17. a) dLM-PEG (15 ºC) b) dLM-gelatin (15 ºC) 
 
This formulation for dLM bioink was prepared by addition of 250 µl of 10% w/v gelatin 
and 55 µl of 150 mM SVA-PEG-SVA in the pre-gel maintained at a temperature below 
15 ºC. This resulted in formation of a soft temperature sensitive gel, which had 
flowablility only after incubating for 1.5-2 h at 37 ºC, designated as bioink or dLM 
bioink. This behaviour of the bioink can be attributed to the property of gelatin to form 
solid gel at a temperature below 20 ºC and bahave as  a liquid above 35 ºC. Thus, when 
gelatin is added to pre-gel which is maintained at low temperature, it tends to solidify the 
whole bioink, followed by addition of SVA-PEG-SVA. On incubating the bioink for at 
37 ºC, the amine groups on gelatin and collagen starts to form amide linkage with 
carboxyl group on SVA-PEG-SVA. After approximately 2 h, the bioink is crosslinked 
and it acquires a viscoelastic characterstic that is suitable for biocompatible printing 
process. In future studies, more formulation of dLM bioink can be investigated to 
improve the bioink properties. A secondary crosslinking material post printing can also 
be utilized for developing a robut 3D structure for long term analysis. The main concern 
while developing the dLM bioink was the repeatability of its formulation. Though exact 
same quantity of materials were used every time, however due to numerous reasons like, 
difference in veal liver meat and decellularization conditions, the dLM bioink 
formulation varied  a little. This didn’t affect the bioprinting process, but a small 
difference in the values of available free amines after crosslinking and cell viability assay 
was observed.  
 
The dLM bioink was compared and analysed with dLM-gelatin, dLM-PEG and ph 
adjusted dLM. dLM-PEG formed  hard gel, when 60 µl was added to 750 µl dLM and 
dLM-gelatin formed semi-soft gel at a concentration of 346 µl /ml of dLM bioink. 
Further, the compositon of the dLM bioink was optimized by checking the spreadibility 
with spatula and flowability by extruding the bioink through a blunt end needle (300 
micron diamter) after incubating the bioink for 2 h, as shown in figure 18. As seen in 
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figure 18 a), the optimized bioink showed viscoelastic behaviour and could be spread 
with spatula. Similar behaviour of the bioink was observed, when extruded with a 300 
micron needle to build a layer by layer structure which retained its shape, as shown in 
figure 18 b). However, this behaviour was absent in ph adjusted dLM, dLM-PEG and 
dLM-gelatin. These gels were further tested for rheology and degree of crosslinking. 
 
   
 
Figure 18. (a) Initial analysis of spreadability and (b, c) flowability of the dLM bioink 
using a 300 micron needle. 
 
4.4 Robustness of decellularized liver matrix bioink 
The optimized bioink was characterized to check its robustness and crosslinking. This 
was achieved by performing rheological measurements and TNBS assay, which 
supported the formation of  the bioink with the optimized composition. 
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4.4.1 Rheology  
Rheological properties of the pH adjusted dLM, bioink, dLM-Gelatin and dLM-PEG 
were measured at 37 ºC to compare and mimic the condition during the bioprinting 
process. By the end of the rheological tests, the samples were unloaded from the parallel 
plate, where they exhibited gelation, as shown in figure 19.  
 
 
Figure 19. Gelation of dLM bioink at 37 ºC after rheological measurements in the 
parallel plate rheometer. 
 
It was observed that all the four bioinks exhibited shear thinning behavior with their 
viscosities decreasing with increasing shear rate in the measured range, as shown in 
figure 20. During bioprinting, it is important that the cells in the bioink does not endure 
excessive stress. Usually, the generated shear rate in the bioprinting of dLM pre-gel is in 
the range of 3.0-10 s
-1,
 depending on the viscosity of the bioink. The viscosity at 10 s
-1
 for 
pH adjusted dLM, dLM bioink, dLM-PEG and dLM-gelatin are illustrated in table 3. As 
observed from the data in table 3, the increase in the viscosity of bioink was 9.27 times of 
the pH adjusted dLM, whereas dLM-PEG and dLM-Gelatin increased 4.56 and 21.65 
times. Thus, there is a clear modification or change in the material, when crosslinking 
agents (SVA-PEG-SVA) and formulation enhancers are used (gelatin).The viscosity of 
the dLM bioink in the shear range of 3 - 10 s
-1
 is from 6.16 - 2.12 Pa s
-1
 at 37  ºC, which 
is compatible to generate a robust cell laden 3D construct without any major effect on 
cell viability. The viscosity of pH adjusted  dLM in the required shear range is less than 
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the dLM bioink, as crosslinking induces robustness which in turn increases the viscosity. 
dLM-PEG exhibited highest viscosity due to excessive amide bond formation that might 
have adverse effect on cell function and viability, wheraes dLM-Gelatin had relatively 
lower viscosity than bioink which is good for cell viability and function.  Thus, dLM-
PEG and bioink excessive robustness and strength with their enhanced viscosity as 
compared to dLM-gelatin, dLM bioink and ph adjusted dLM. 
 
Figure 20. Viscosity of dLM bioink, pH adjusted dLM, dLM-PEG and dLM-gelatin at 37 
ºC. All experiments done in triplicates. P<0.05 
 
 
Table 3. Viscosity at 10 s
-1
 for pH adjusted dLM, dLM bioink, dLM-PEG and dLM-
gelatin 
Material Viscosity at 10 s
-1 
(Pa.s) 
pH adjusted dLM 0.23 
dLM bioink 2.12 
dLM-PEG 1.05 
dLM-gelatin 4.98 
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The storage (G’) and loss modulus (G’’) of all the four gels revealed that the dLM bioink 
as the most suitable for bioprinting process, as shown in figure 21. The storage and loss 
modulus were measured in oscillatory conditions at 37 ºC after incubating the gels at 37 
ºC for 2 h to evaluate their elastic and viscous behaviour respectively. All the four gels 
behaved as a crosslinked material and exhibited higher storage modulus than loss 
modulus, which is a prerequisite in bioprinting process. dLM bioink exhibited highest 
storage modulus, which would support the 3D construct to retain its shape post printing. 
The storage modulus and loss modulus of dLM bioink, pH adjusted dLM, dLM-PEG and 
dLM-gelatin at 10 rad/s are shown in table 4. The storage modulus of bioink at 10 rad/s 
frequency was 1.5 times more than dLM-gelatin, 3.9 times more than dLM-PEG and 4.4 
times more than pH adjusted dLM, making it most suitable to retain the printed structure. 
From the storage modulus and loss modulus data in table 4, it was clear that dLM bioink 
was the most viscoelastic, which will further enhance cell proliferation and activity. 
Figure 21. Dynamic modulus of dLM bioink, pH adjusted dLM, dLM-PEG and dLM-
gelatin with varying frequency at 37 ºC. All experiments run in triplicates. P<0.05 
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Table 4. Loss modulus and storage modulus of for pH adjusted dLM, dLM bioink, dLM-
PEG and dLM-gelatin at 10 rad/s 
Material Storage modulus at 10 
rad/s (G’) 
Loss Modulus at 10 
rad/s (G’’) 
pH adjusted dLM 839 129.4 
dLM bioink 3759 1111 
dLM-PEG 948 195.1 
dLM-gelatin 2469 1044 
 
4.4.2 Degree of crosslinking 
Furthermore, TNBS assay was done to estimate the available amines after crosslinking 
for 2 h at 37 ºC, which can be used to evaluate the degree of crosslinking, as shown in 
figure 22. More the number of free amines, less is the degree of crosslinking. Assuming 
that dLM pre-gel contains 100% of the available free amines, dLM-gelatin, pH adjusted 
dLM, dLM bioink and dLM-PEG exhibited 94.49% (±6.03), 88.55% (±2.1), 75.3% 
(±3.03) and 55.45% (±4.5) available free amines, respectively.  Note that, dLM bioink 
has intermediate amount of free amines implying formation of a soft gel with adequate 
crosslinking, which is a pre-requisite in bioprinting. On the other hand, dLM-gelatin 
contains maximum number of free amines followed by pH adjusted dLM implying least 
degree of crosslinking. This can be attributed to the lack of PEG as crosslinker in pH 
adjusted dLM and dLM-gelatin, whereas addition of PEG in bioink and dLM-PEG 
enhanced crosslinking and resulted in less number of free amines. However, addition of 
PEG alone to dLM results in excessive crosslinking making it a hard gel unsuitable for 
bioprinting process. Gelatin along with PEG enhances the bioink formulation and degree 
of crosslinking, thus improving the gelation kinetics. So it was realised that addition of 
both gelatin and PEG in the bioink formulation was imperative for providing the required 
rheological properties for fabrication of 3D constructs.  
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Figure 22. Concentration of available amines in dLM pre-gel, dLM-gelatin, pH adjusted 
dLM, dLM bioink (soft gel) and dLM-PEG (hard gel). All experiments run in triplicate. 
Error bar demonstrates standard deviation.  
4.5 Cell viability and proliferation 
Cell viability assay was conducted for the dLM bioink to identify its biocompatibility 
with the cells at day 1, 3 and 7. In the Live/Dead assay, immortal cell line at a 
concentration of 10
6 
cells/ml of bioink were incubated at 37 ºC and 5% CO2. dLM bioink 
exhibited very good biocompatibility with almost no detectable dead cells, as shown in 
figure 23. At day 1, almost all cells were seen to be alive and well spread in the scaffold 
with very minimal dead cells. On day 3, the number of cells increased and small cell 
clusters were seen. On day 7, the cells spread on the whole gel area and few dead cells 
were seen. The main concern while taking images of the cells was the uneven 3D surface 
that only focussed on one part of the image, as seen in figure 23 day 3.  
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Figure 23. Live/Dead assay at day 1, 3 and 7 with green (live) cells and red (dead) cells 
(scale bar 100 µm) at 10x zoom  
 
Furthermore, the cell viability of bioink structure was accurately measured using MTT 
assay at day 1, 3 and 7 of cell mixing, as shown in figure 24.  The bioink structure 
without cells was used as control, which was subtracted from the sample value at 
respective days. The number of cells increased continously from day 1 till day 7. The cell 
viability incresed from 12% in day 3 (±0.07) and 44% in day 7 (±0.03) as compared to 
day 1 (±0.05).  Though this data does not provide the actual number of cells present at 
each day, but it is used to compare the live cells at various time points. This significantly 
shows an increase of live cells that reduces MTT to form formazan at day 1, 3 and 7. 
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Figure 24. MTT assay at day 1, 3 and 7. All samples done in triplicates. Error bar 
demonstrates standard deviation.  
4.6 Bioprinting 
Bioprinting was an important evaluation stage of our dLM bioink, where 3DDiscovery™ 
from regenHu was used to print a simple 2 layer grid structure in a six well plate. There 
were various parameters to be adjusted for obtaining maximum efficiency of the bioink 
including pressure, printing speed, nozzle diameter and temperature control. The 
modularity and flexibility of the 3D bioprinter are important criteria that decides their 
final application. This stage of optimising the parameters was extremely time consuming 
and required a good amount of bioink. This can be considered one of the drawback of the 
bioprinting technique. Since the dECM obtained is very low in quantity, it was a 
challenge to minimize the wastage of the bioink during the process of optimising the 
parameters. But once the parameters are optimised, it would provide repeatability and 
control in the results without any further adjustments.  
 
For this process, 300 micron nozzle diameter was used to print on a 24 well plate with 
printing speed of around 60 mm/s. The size of the construct was aorund 8 mm and height 
around 1 mm, as shown in figure 25. Though the size of the printed construct is few mm, 
but it was visble that the bioink was able to retain its structure even after two weeks of 
printing. No flow behaviour was observed post printing in the structure implying increase 
in shear after printing and good crosslinking. 
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Figure 25. Bioprinting with 3DDiscovery™ bioprinter to print a two layer grid structure 
in a 24 well plate. Scale bar 8 mm. 
 
 
Further work can be done, where cells can be added into the bioink to test the 
compatibility of the cell loaded bioink with the bioprinting process. It is hypothesised that 
the bioink will retain good biocompatibility with high cell viability and activity after the 
printing process.  
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5. CONCLUSION AND FUTURE ASPECTS 
3D bioprinting is a relatively new but a rapidly evolving biofabrication technology that 
has created a hope in the tissue engineering world for faster and precise development of 
3D tissues and organs. These tissue/organs can be utlized in organ transplant, injury or 
animal testing models. dECM is a promising biomaterial that can efficiently mimic the 
complexity of natural ECM of a specific tissue. This property gives advantage in printing 
a 3D construct that can recreate the microenvironment typical to a living tissue.  
 
The aim of this thesis was to develop a robust biocompatible dLM bioink suitable for 
bioprinting. In this study, for the first time native liver tissue was decellularized, using 
both physical and chemical decellularization processes, wherein the structural integrity of 
the native tissue was lost but, the ECM components like GAGs and collagen were 
retained and utilized for providing tissue specific microenvironment for cellular activity 
and viability. DNA quantification confirmed the absence of DNA, while DMMB assay 
and Hydroxyproline assay confirmed high percentage of GAGs and collagen 
respectively. These results are in line with the previous work conducted by Pati et al. 
(2014) with adipose, cartilage and heart tissue. The decellularized liver tissue was 
transformed into a soluble dLM by digesting the tissue in pepsin that cleaved the 
telopeptide parts of the collagen allowing its solublization in acetic acid (Lee et al., 
2010). This digested dLM solution was transformed to dLM pre-gel by adjusting the pH 
to 7, which behaved as temperature sensitive material forming a solid gel at a temperature 
around 37 ºC. The printability and flow characteristics of this ph adjusted dLM was 
improved by crosslinking using SVA-PEG-SVA with addition of gelatin to form dLM 
bioink. The rheology characteristics and degree of crosslinking of the dLM bioink was 
compared and analysed with dLM-gelatin, dLM-PEG and ph adjused dLM. The results 
illustrated bioink as most suitable for printing with suitable viscosity (flow 
characteristics), good crosslinking (soft gel) and highest storage modulus than loss 
modulus among all the gels, which was central to bioprinting. dLM-PEG formed hard gel 
with low storage modulus, whereas dLM-gelatin formed semi-soft gel with low degree of 
crosslinking. However, all the gels exhibited shear thinning behaviour.  
 
The developed dLM bioink was cytocompatible and supported cell viability for a period 
of 7 days. The number of live cells and formazan formation increased from day 1 till day 
7 indicating increase in the number of cells. Further, the dLM bioink was used for 
printing through 3DDiscovery, an extrusion based bioprinter in a 2 layer grid structure. 
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The dLM bioink was able to retain the 3D structure without any flow characteristic post 
printing.  
 
Throughout the experiments, repeatability of the dLM bioink concentration was the main 
concern.  This is a common problem when working with natural materials, but it can be 
fixed by highly optimising the whole process of development of dLM bioink. In addition 
to this, cell visibility in one plane in the fluorescence microscope was difficult due to the 
uneven scaffold layer. In the future work, confocal microscopy will be utilized to observe 
the cells in the 3D environment. In spite of many problems, these results provided a good 
insight for biofabrication of a 3D construct using dLM bioink based on gelatin and SVA-
PEG-SVA.  
 
Previous studies related to dECM of different types of tissues and bioprinting have been 
succesfully conducted. Whole liver decellularization has been succesfully conducted 
elsewhere (Mazza, G. et al, 2015), wherein the human liver was perfused with 
decellularizing agents through the hepatic veins and inferior vena cava. This resulted in 
preservation of liver structure and vasculature, which can be recellularized with multiple 
liver specific cell types, like hepatocytes, which will be used in organ transplantaion in 
future. In contrast to this work, the liver tissue loses its structural characteristics in this 
thesis work. This results in preservation of the ECM components which can be further 
designed and bioprinted providing several applications, like organ transplantaion, in-vivo 
studies or toxicological studies. This thesis work is similar to the work performed 
previously by Falguni et al. (2014), wherein adipose, heart and cartilage tissues are 
decellularized and bioprinted on polycaprolactone as secondary scaffold. The bioink in 
their study was not robust enough to maintain the 3D structure by itself, hence, a 
secondary support was required. However, in our study crosslinking of the dECM of liver 
tissue provided enough mechanical strength and robustness that the need for a secondary 
support was eliminated.  
 
In future, this bioprinting technique of depositing dLM bioink can satisfy several 
important needs in the field of animal testing models and drug toxicology testing. Further 
work can be done to develop a hepatic lobule that can mimic the biochemical gradient of 
the native tissue, since the dLM bioink is robust with high biocompatibility.  
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Appendix 1: Calibration curves of DNA quantification, DMMB 
assay and Hydroxyproline assay 
 
For the calculation of DNA, GAGs and collagen content, a calibration curve was plotted 
using Sigma Aldrich DNA fluorescence kit, between the total concentration (ng/ml) of 
DNA, collagen and GAGs and relative fluorescence units, as seen in graph.  The linear 
square regression equation of the line generated by samples (n=3) was also plotted in 
form of y=mx+b, where, 
 
y= Emission as relative fluorescence units 
m= the slope 
x= DNA concentration 
b= intercept 
R= Regression value 
 
The regression value R
2
 demonstrates a fraction between 0.0 and 1.0. If the value is 0, 
then there is no relation between X and Y axis, but, if the value is near to 1.0, all points or 
values lie in one lie with minimum or no scatter. Thus, the regression value for the three 
curves as shown in grapH is 0,9887, 09199 and 0,954, which satisfies the results obtained 
during the dLM analysis.  
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Varying GAGs concentration with absorbance at 492 nm  
 
 
Varying GAGs concentration with absorbance at 492 nm 
 
From the equations obtained from the graph (a), the concentration of DNA in native 
tissue and dLM was calculated resulting in 1.57 % of DNA present in the dLM relative to 
native tissue.  
On the other hand, the GAGs and collagen content in dLM relative to the native tissue 
was 26.26% and 91% respectively. 
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